You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

SHINGRIX overview

What Shingrix is used for [1]

Shingrix is a vaccine that helps to protect adults against shingles (herpes zoster) and post-herpetic neuralgia (PHN), the long-lasting nerve pain that follows shingles.

Shingrix is given to:

  • adults 50 years and above;
  • adults 18 years and above who are at increased risk of shingles.
  • Shingrix cannot be used to prevent chickenpox (varicella).

How Shingrix is given

  • Shingrix is given as an injection into a muscle (usually in the upper arm).
  • You will receive 2 injections 2 months apart. If flexibility in the vaccination schedule is necessary, the second dose can be administered between 2 and 6 months after the first dose. Based on your medical condition, your doctor may also recommend that you receive the second injection 1 month after the first injection.
  • You will be informed when you should come back for the second dose of Shingrix

Safety Information

For safety information on SHINGRIX, please see the SHINGRIX patient information leaflet (PIL). This link will take you to www.medicines.ie which is a non-GSK website.

View Patient information leaflet 

References:

  1. https://www.medicines.ie/medicines/shingrix-powder-and-suspension-for-suspension-for-injection-herpes-zoster-vaccine-recombinant-adjuvanted--35192/patient-info#tabs

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to HPRA Pharmacovigilance on their website: www.hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

SHINGRIX is a registered trademark of the GlaxoSmithKline group of companies.